<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20241031//EN"
        "https://jats.nlm.nih.gov/publishing/1.4/JATS-journalpublishing1-4.dtd">
<article         dtd-version="1.4">
            <front>

                <journal-meta>
                                                                <journal-id>ktd</journal-id>
            <journal-title-group>
                                                                                    <journal-title>Kocatepe Tıp Dergisi</journal-title>
            </journal-title-group>
                                        <issn pub-type="epub">3061-9904</issn>
                                                                                            <publisher>
                    <publisher-name>Afyonkarahisar Sağlık Bilimleri Üniversitesi</publisher-name>
                </publisher>
                    </journal-meta>
                <article-meta>
                                        <article-id/>
                                                                                                                                                                                            <title-group>
                                                                                                                        <trans-title-group xml:lang="en">
                                    <trans-title>Hepatit B AŞISI SonraSI Gellsen Guillain Barre Sendromu Olgusu</trans-title>
                                </trans-title-group>
                                                                                                                                                                                                <article-title>Hepatit B AŞISI SonraSI Gellsen Guillain Barre Sendromu Olgusu</article-title>
                                                                                                    </title-group>
            
                                                    <contrib-group content-type="authors">
                                                                        <contrib contrib-type="author">
                                                                <name>
                                    <surname>Kaplan</surname>
                                    <given-names>Yuksel</given-names>
                                </name>
                                                            </contrib>
                                                                                </contrib-group>
                        
                                        <pub-date pub-type="pub" iso-8601-date="20060801">
                    <day>08</day>
                    <month>01</month>
                    <year>2006</year>
                </pub-date>
                                        <volume>7</volume>
                                        <issue>2</issue>
                                                
                        <history>
                                    <date date-type="received" iso-8601-date="20150508">
                        <day>05</day>
                        <month>08</month>
                        <year>2015</year>
                    </date>
                                            </history>
                                        <permissions>
                    <copyright-statement>Copyright © 1999, Kocatepe Tıp Dergisi</copyright-statement>
                    <copyright-year>1999</copyright-year>
                    <copyright-holder>Kocatepe Tıp Dergisi</copyright-holder>
                </permissions>
            
                                                                                                                        <abstract><p>Hepatit B aşısı, ciddi hastalıklara yol açabilen hepatit B virus infeksiyonlarından koruma amacıyla kullanı— lan bir aşıdır. Aşının etkili ve emniyetli olduğu gösterilmiş olup yüksek risk grubunda olan kişilere proflaksi amaçlı önerilmektedir. Guillain Barre Sendromu, hepatit B aşısından sonra oldukça nadir görülen bir komplikasyondur. Bu sunumda hepatit B aşısı sonrası geliştiği düşünülen bir Guillain Barre Sendromu olgusu tartışılacaktır</p></abstract>
                                                            
            
                                                                                        <kwd-group>
                                                    <kwd>Guillain Barre Sendromu</kwd>
                                                    <kwd>   hepatit B aşısı</kwd>
                                                    <kwd>   otoimmünite</kwd>
                                            </kwd-group>
                            
                                                <kwd-group xml:lang="en">
                                                    <kwd>-</kwd>
                                            </kwd-group>
                                                                                                                                        </article-meta>
    </front>
    <back>
                            <ref-list>
                                    <ref id="ref1">
                        <label>1</label>
                        <mixed-citation publication-type="journal">Öge E (editör). Nöroloji, İstanbul Tıp Fakültesi Te- mel ve Klinik Bilimler ders kitapları. ln: Öge E, Parman Y. Polinöropatiler. 1.baskı, İstanbul: Nobel tıp kitabevleri, 2004: 591-623.</mixed-citation>
                    </ref>
                                    <ref id="ref2">
                        <label>2</label>
                        <mixed-citation publication-type="journal">Rostami AM. Pathogenesis of immune-mediated neuropathies. Pediatr. Res. 1993;33:590—4 3. Shaw FE Jr, Graham DJ, Guess HA, et al. Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the Şrst three years. Am J Epidemiol. 1988; 127(2): 337—52.</mixed-citation>
                    </ref>
                                    <ref id="ref3">
                        <label>3</label>
                        <mixed-citation publication-type="journal">McMahon BJ, Helminiak C, Wainwright RB, et al. Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons. Am J Med. 1992; 92(3): 254-6.</mixed-citation>
                    </ref>
                                    <ref id="ref4">
                        <label>4</label>
                        <mixed-citation publication-type="journal">Sindem E, Schroder JM, Krismann M, Malin JP. Inşammatory polyradiculoneuropathy with spinal cord involvement and lethal outcome after hepatitis B vaccination. J Neurol Sci. 2001; 186(1-2): 81-5.</mixed-citation>
                    </ref>
                                    <ref id="ref5">
                        <label>5</label>
                        <mixed-citation publication-type="journal">Tuohy PG. Guillain-Barre syndrome following immunisation with synthetic hepatitis B vaccine. N Z Med J. 1989 8; 102(863): 114-5.</mixed-citation>
                    </ref>
                                    <ref id="ref6">
                        <label>6</label>
                        <mixed-citation publication-type="journal">Kakar A, Sethi PK. Guillain Barre syndrome associated with hepatitis B vaccination. Indian J Pe- diatr. 1997; 64(5): 710-2.</mixed-citation>
                    </ref>
                                    <ref id="ref7">
                        <label>7</label>
                        <mixed-citation publication-type="journal">Seti NK, Reddi R, Anand I, Sethi PK. Gulliane Barre syndrome following vaccination with hepatitis B vaccine. JAssoc Physicians India. 2002; 50:989.</mixed-citation>
                    </ref>
                                    <ref id="ref8">
                        <label>8</label>
                        <mixed-citation publication-type="journal">Terryberry J, Sutjita M, Shoenfeld Y, et al. Myelin- and microbe-speciŞc antibodies in Guillain-Barre syndrome. J Clin Lab Anal. 1995; 9(5): 308—19.</mixed-citation>
                    </ref>
                                    <ref id="ref9">
                        <label>9</label>
                        <mixed-citation publication-type="journal">Shoenfeld Y, Aron-Maor A.Vaccination and autoimmunity-&#039;vaccinosis&#039;: a dangerous liaison? J Autoimmun. 2000; 14(1): 1-10.</mixed-citation>
                    </ref>
                                    <ref id="ref10">
                        <label>10</label>
                        <mixed-citation publication-type="journal">Kongre/Je Tıp Dergisi. Cilt 7 No: 2, Mayıs 2006.</mixed-citation>
                    </ref>
                            </ref-list>
                    </back>
    </article>
